+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Budesonide Inhaler Market by Products Type, Dosage, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011478
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Budesonide Inhaler Market grew from USD 265.99 million in 2023 to USD 290.37 million in 2024. It is expected to continue growing at a CAGR of 9.11%, reaching USD 489.71 million by 2030.

The budesonide inhaler market primarily encompasses the production and consumption of this corticosteroid medication, used for managing respiratory conditions such as asthma and chronic obstructive pulmonary disorder (COPD). Its application is necessitated by the rising incidence of these conditions globally, driven by factors such as urban pollution and smoking. The inhaler's end-use scope mainly includes hospitals, households, and clinics, reflecting its role in acute and long-term respiratory management. Growth in this market is influenced by advancements in drug delivery technologies, increased awareness about respiratory health, and the growing preference for minimally invasive treatment methods. Moreover, manufacturers are exploring potential opportunities in emerging markets where healthcare infrastructure is rapidly developing and there is increased investment in public health initiatives.

A key opportunity lies in the expansion of digital health solutions, such as smart inhaler technologies which can enhance patient adherence and provide real-time data for healthcare providers. This can be a significant differentiator, offering players a competitive edge. However, challenges persist, including stringent regulatory environments, potential side effects of long-term corticosteroid use, and competition from generic alternatives which might impact pricing strategies. Innovating in personalized medicine approaches, where the inhaler's formulation and delivery can be tailored to individual patient needs, is a promising avenue for growth. Additionally, focusing on eco-friendly inhaler designs can address environmental concerns associated with propellants used in metered-dose inhalers.

In terms of market nature, the budesonide inhaler segment is both competitive and steadily evolving, urging stakeholders to continuously adapt. Investing in robust R&D to enhance efficacy and safety profiles, along with strategic collaborations with healthcare providers to improve consumption practices, will be crucial for maintaining market relevance. Continuous monitoring of regulations and technological advancements can guide licensors and marketers in tapping unexplored segments and offering solutions that align with the shifting landscape of healthcare demands.

Understanding Market Dynamics in the Budesonide Inhaler Market

The Budesonide Inhaler Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Upsurge in the Prevalence of Chronic Respiratory Diseases such as Asthma and COPD
    • Soaring Geriatric Population Affected with Respiratory Disorders
    • Increasing Awareness for Hi-Tech Respiratory Disorders
  • Market Restraints
    • Side Effects of Budesonide
  • Market Opportunities
    • Rising Number of Launches in Generic Version of Budesonide Inhaler
    • Further Innovation in Inhaled Therapy for Airways Disease
  • Market Challenges
    • Availability of Alternatives and Technical Difficulties in Drug Delivery

Exploring Porter’s Five Forces for the Budesonide Inhaler Market

Porter’s Five Forces framework further strengthens the insights of the Budesonide Inhaler Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Budesonide Inhaler Market

External macro-environmental factors deeply influence the performance of the Budesonide Inhaler Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Budesonide Inhaler Market

The Budesonide Inhaler Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Budesonide Inhaler Market

The Budesonide Inhaler Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Budesonide Inhaler Market

The Budesonide Inhaler Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Budesonide Inhaler Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Chiesi Farmaceutici S.p.A., Cipla Limited, Cosmo Pharmaceuticals N.V., Lunan Pharmaceutical Group, Lupin Limited, Manus Aktteva Biopharma LLP, Novartis International AG, Orion Corporation, Pfizer Inc., Synmosa Biopharma Corporation, Takeda Pharmaceutical Company Limited, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Budesonide Inhaler Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Products Type
    • Inhalants
    • Nebulizers
  • Dosage
    • Aerosols
    • Dry Powder
    • Spray
    • Suspension
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Upsurge in the Prevalence of Chronic Respiratory Diseases such as Asthma and COPD
5.1.1.2. Soaring Geriatric Population Affected with Respiratory Disorders
5.1.1.3. Increasing Awareness for Hi-Tech Respiratory Disorders
5.1.2. Restraints
5.1.2.1. Side Effects of Budesonide
5.1.3. Opportunities
5.1.3.1. Rising Number of Launches in Generic Version of Budesonide Inhaler
5.1.3.2. Further Innovation in Inhaled Therapy for Airways Disease
5.1.4. Challenges
5.1.4.1. Availability of Alternatives and Technical Difficulties in Drug Delivery
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Budesonide Inhaler Market, by Products Type
6.1. Introduction
6.2. Inhalants
6.3. Nebulizers
7. Budesonide Inhaler Market, by Dosage
7.1. Introduction
7.2. Aerosols
7.3. Dry Powder
7.4. Spray
7.5. Suspension
8. Budesonide Inhaler Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Americas Budesonide Inhaler Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Budesonide Inhaler Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Budesonide Inhaler Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. BUDESONIDE INHALER MARKET RESEARCH PROCESS
FIGURE 2. BUDESONIDE INHALER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BUDESONIDE INHALER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BUDESONIDE INHALER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BUDESONIDE INHALER MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. BUDESONIDE INHALER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BUDESONIDE INHALER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BUDESONIDE INHALER MARKET DYNAMICS
TABLE 7. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY INHALANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY AEROSOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DRY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. CANADA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 31. CANADA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. CHINA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 48. CHINA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. INDIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 51. INDIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. ITALY BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 103. ITALY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. POLAND BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 115. POLAND BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. QATAR BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 118. QATAR BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY PRODUCTS TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. BUDESONIDE INHALER MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. BUDESONIDE INHALER MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Budesonide Inhaler market, which are profiled in this report, include:
  • Abbott Laboratories
  • AstraZeneca PLC
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • Cosmo Pharmaceuticals N.V.
  • Lunan Pharmaceutical Group
  • Lupin Limited
  • Manus Aktteva Biopharma LLP
  • Novartis International AG
  • Orion Corporation
  • Pfizer Inc.
  • Synmosa Biopharma Corporation
  • Takeda Pharmaceutical Company Limited
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information